Medicare GLP-1 discount: $50 monthly cost starts in July

The new Medicare program offers substantial savings on weight-loss medications like Wegovy and Ozempic through December, with ...

What You Need To Know About The GLP-1 Medicare Bridge, $50 Drugs

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...
Government Executive

More GLP-1 options are coming for federal retirees, but they come with a catch

A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to ...

People with eating disorders are taking GLP-1s, and doctors are alarmed

Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are ...
Becker's Hospital Review

GLP-1s and cancer outcomes: What new research shows

GLP-1 cancer outcomes research shows links to lower incidence and better survival across multiple tumor types in recent clinical studies.
HR Dive

Why cover GLP-1s? They’ll lower employer healthcare costs, study says

Companies on the fence about offering an employee benefits plan that covers GLP-1s may find the following data helpful: A report from risk consultation firm Aon, released Jan. 13, suggests workers’ ...

Ontada Study Presented at ASCO 2026 Examines Real-World Use of GLP‑1 Receptor Agonists and Survival Outcomes Across Common Cancers in U.S. Community Oncology

Ontada will present a real-world research study at the ASCO Annual Meeting examining GLP-1 receptor agonist utilization and overall survival outcomes.